NOVAVAX INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Novavax Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Novavax Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $12M, a 42% decline year-over-year.
  • Novavax Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $53.4M, a 45.3% decline year-over-year.
  • Novavax Inc annual Share-based Payment Arrangement, Expense for 2023 was $85.4M, a 34.5% decline from 2022.
  • Novavax Inc annual Share-based Payment Arrangement, Expense for 2022 was $130M, a 29% decline from 2021.
  • Novavax Inc annual Share-based Payment Arrangement, Expense for 2021 was $184M, a 43.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $53.4M $12M -$8.71M -42% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $62.1M $14.1M -$6.19M -30.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $68.3M $11.6M -$17.1M -59.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $85.4M $15.7M -$12.1M -43.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $97.5M $20.8M -$10.8M -34.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $108M $20.3M -$17.8M -46.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $126M $28.6M -$4.29M -13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $130M $27.8M -$4.4M -13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $135M $31.5M -$13.7M -30.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $148M $38M -$15.1M -28.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $163M $32.9M -$20.1M -37.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $184M $32.2M -$18.3M -36.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $202M $45.3M -$20.4M -31.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $222M $53.1M +$45.2M +570% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $177M $53.1M +$49.1M +1238% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $128M $50.4M +$46.2M +1088% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $81.8M $65.7M +$63.1M +2404% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $18.8M $7.93M +$3.31M +71.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $15.5M $3.97M -$1.59M -28.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $17M $4.25M -$141K -3.21% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $17.2M $2.62M -$1.81M -40.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $19M $4.62M +$369K +8.68% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $18.6M $5.56M +$313K +5.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $18.3M $4.39M -$2.36M -35% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $20.7M $4.43M +$100K +2.31% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $20.6M $4.25M -$263K -5.83% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $20.8M $5.25M +$1.03M +24.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $19.8M $6.75M +$2.97M +78.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 $16.8M $4.33M -$825K -16% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $17.7M $4.51M -$743K -14.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $18.4M $4.21M -$748K -15.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $19.2M $3.79M -$368K -8.86% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $19.5M $5.16M +$391K +8.21% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $19.1M $5.26M +$2.68M +104% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $16.5M $4.96M +$3.03M +157% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $13.4M $4.15M +$2.65M +176% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $10.8M $4.77M +$3.07M +182% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $7.71M $2.58M +$728K +39.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $6.98M $1.93M +$892K +85.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $6.09M $1.51M +$811K +117% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $5.28M $1.69M +$1.03M +155% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $4.25M $1.85M +$1.21M +190% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $3.04M $1.04M +$557K +115% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $2.48M $696K +$274K +64.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $2.21M $663K +$170K +34.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $2.04M $638K +$49K +8.32% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.99M $483K -$104K -17.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $2.09M $422K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $493K -$49K -9.04% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $589K -$114K -16.2% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $587K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $542K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $703K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.